Immunocore Hldgs Q2 EPS $(0.20) Beats $(0.23) Estimate, Sales $97.964M Beat $94.428M Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
Immunocore Hldgs (NASDAQ:IMCR) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.23) by 13.79 percent. This is a 13.04 percent increase over losses of $(0.23) per share from
Immunocore Hldgs (NASDAQ:IMCR) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.23) by 13.79 percent. This is a 13.04 percent increase over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $97.964 million which beat the analyst consensus estimate of $94.428 million by 3.74 percent. This is a 29.93 percent increase over sales of $75.400 million the same period last year.